In conclusion, Tan-IIA suppressed METTL3-mediated m6A modification of TRIB3 mRNA, resulting in the repression of HCC cell proliferation, invasion, and stemness, providing a new theoretical basis to support Tan-IIA as a drug against HCC. The gene discussed is TRIB3; the disease is hepatocellular carcinoma.